What Researchers Did
Researchers conducted a descriptive review of hyperbaric oxygen therapy (HBOT), examining its history, mechanisms of action, and current application in chronic wounds, with a focus on diabetic foot ulcers.
What They Found
The review found that hyperbaric oxygen therapy (HBOT) is utilized for various conditions, including chronic wounds which affect approximately 6.5 million Americans annually. Despite its use, the cellular and physiological mechanisms by which HBOT benefits chronic wounds are not fully understood, and significant skepticism exists regarding its efficacy due to a lack of high-quality research.
What This Means for Canadian Patients
Canadian patients with chronic wounds, such as diabetic foot ulcers, may encounter hyperbaric oxygen therapy (HBOT) as a treatment option. However, they should be aware that while HBOT is used, its exact mechanisms and overall efficacy in chronic wound management are still debated due to limited high-quality evidence.
Canadian Relevance
This review article has no direct Canadian connection.
Study Limitations
A significant limitation highlighted is the paucity of high-quality research available to definitively establish the efficacy of hyperbaric oxygen therapy in chronic wounds.